Consolidated Construction Consortium Limited

Industrials — Engineering & Construction · NSE

₹12.99−₹0.37 (−2.77%)

DalalBaazaar Score

58 / 100

🟡 Moderate

Verdict

CAUTION

Risk

Very High

Driven by negative free cash flow, the company is currently loss-making, micro-cap size, which brings thin liquidity.

In simple words: The company is currently losing money, though profits are falling even as sales grow. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:59 pm

Understanding the Business

Company site ↗

The 60-second version of Consolidated Construction Consortium Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Consolidated Construction Consortium Limited, together with its subsidiaries, engages in the provision of construction design, engineering, procurement, construction, and project management services in India and internationally.

IndustryEngineering & Construction

SectorIndustrials

Employees554

Annual revenue₹295 Cr

How does it make money?

Turns over ₹295 Cr a year. Of every ₹100 of sales, about ₹27 reaches shareholders as profit, with ₹2 left at the operating level before interest, tax and depreciation. Each of its 554 employees supports ₹53.2 lakh of revenue a year, the signature of a people-led business.

Revenue / employee₹53.2 lakh

Who are its competitors?

The closest listed comparisons in its industry are LARSEN & TOUBRO LTD., ADANI PORT & SEZ LTD, SIEMENS LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 22.8%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 28.3% against a peer median of 14.1% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

Peer median ROE14.1%

What has been driving growth?

Sales and margins have both contributed to where profit is now. Over 3 years revenue moved +112% while net margin moved -133% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+112%

Margin effect-133%

DalalBaazaar Score

58/ 100

Moderate

Weighted across six categories. Every point is explained below.

✗ Beta of 6.40 — amplifies market moves in both directions
✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

67/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

25/ 100

Expensive

What you are being asked to pay, ignoring how good the business is.

A good business, but the price already reflects that. The quality is real; the question is whether you are overpaying for it today.

vs. its own history

Not enough price and earnings history

vs. sector peers

Not enough peers with a usable P/E

vs. generic bands

N/A

No P/E — the company is lossmaking

EV/EBITDA

76.9x

PEG

—

What's Good / What's Bad

🟢 What's Going Well4

Margins are improving
EBITDA margin is up from -20.8% to 2.5% over 3 years.
Debt is being paid down
Total debt is down 100% over 3 years.
High return on capital employed
ROCE of 22.8% is the mark of a business that converts capital into profit efficiently.
Very low debt
Debt/Equity of 0.11x leaves the balance sheet with plenty of headroom.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

1 item require attention · 1 watch

🟡Free cash flow is negativeFinancial
Free cash flow was -₹103 Cr in the latest year.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 22.8% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from -20.8% to 2.5%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Deleveraging frees up earnings
Debt is down 100% over 3 years. Every rupee of interest not paid drops to the bottom line, so profit can grow even if revenue does not.

🔴 Bear CaseWhat could go wrong?

Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 21% a year✓ 28.5% CAGR
Latest reported year was 134.4%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 0%✓ 2.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹103 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 0.0x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 20%✓ 22.8%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

7 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✗ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✗ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

4 good · 3 neutral · 4 weak

Market Cap

₹580 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

Not meaningful

Loss-making

Earnings are negative, so a P/E multiple can't be read here

P/B Ratio

2.08x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹-0.08

Loss-making

Negative earnings per share — the business is losing money

ROE

28.3%

Strong

Strong capital efficiency

ROCE

22.8%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

0.11x

Low

Conservative leverage

Revenue Growth (YoY)

134.4%

Healthy

Healthy top-line growth

Profit Growth (YoY)

-9.8%

Falling

Profits are shrinking

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹103 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

Operating Margin

-8.9%

Weak

Thin margins leave little room for error

Net Margin

-1.2%

Weak

Very little revenue reaches the bottom line

Current Ratio

1.62

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

6.40

High swing

Swings more than the market in both directions

52W Range Position

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

13.3 / 14.2

Bearish alignment (short < long)

Price vs SMA 200

Below

Long-term downtrend

RSI (14)

42.5

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹139 Cr	₹130 Cr	₹181 Cr	₹295 Cr	+28.5%
EBITDA	-₹29 Cr	₹61 Cr	₹7 Cr	₹7 Cr	—
EBITDA Margin	-20.8%	47.1%	3.7%	2.5%	—
PAT (Net Profit)	-₹113 Cr	₹673 Cr	₹88 Cr	₹79 Cr	—
EPS	₹-2.82	₹16.88	₹2.16	₹1.77	—
ROE	—	2437.5%	43.9%	28.3%	—
ROCE	—	736.8%	46.8%	22.8%	—
Total Debt	₹1,516 Cr	₹141 Cr	₹0 Cr	₹0 Cr	-94.2%
Free Cash Flow	-₹1 Cr	₹50 Cr	₹155 Cr	-₹103 Cr	—

🟢 Revenue has grown at 28.5% a year over 3 years.

🟢 EBITDA has turned positive, from -₹29 Cr to ₹7 Cr.

🟢 EBITDA Margin has risen from -20.8% to 2.5% over 3 years (+23.3 pts).

🟢 PAT (Net Profit) has turned positive, from -₹113 Cr to ₹79 Cr.

🟢 EPS has turned positive, from ₹-2.82 to ₹1.77.

🔴 ROE has fallen from 2437.5% to 28.3% over 3 years (-2409.1 pts).

🔴 ROCE has fallen from 736.8% to 22.8% over 3 years (-714.0 pts).

🟢 Total Debt has shrunk at 94.2% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹495 Cr

Total Liabilities

₹216 Cr

Cash & Equivalents

₹15 Cr

Operating Cash Flow

-₹98 Cr

Capex

-₹5 Cr

Shareholding (proxy)

Institutional Holding

8.9%

Insider Holding

66.5%

Corporate Actions

Ex-Dividend Date

16 Jun 2011

Peer Comparison

Company	P/E	ROE
LARSEN & TOUBRO LTD.	30.1x	15.2%
ADANI PORT & SEZ LTD	29.9x	14.1%
SIEMENS LTD	88.8x	10.5%

Recent News

1 positive3 mixed2 general

CCCL Share Price Near 52-Week Low on Weak Trend Signals

Univest, 09 Oct

CCCL Bags ₹220 Crore Orders; Shares Rise 4.81% On Update

HDFC Sky, 11 AugPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Consolidated Construction Consortium Limited Issues Clarification on Share Price Movement Following Exchange Inquiry

scanx.trade, 10 Apr

Consolidated Construction Consortium reports consolidated net loss of Rs 5.49 crore in the June 2026 quarter

Business Standard, 29 JulResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

CCCL Results Preview Ahead of the Sep 2026 Quarter

Univest, 17 SeptResults

🟡Mixed / dependsA results event. The figures on this page update once the new statements reach the data feed, which usually lags the announcement.

Consolidated Construction loss narrows in Q1FY27 as revenue surges 134%

scanx.trade, 28 JulResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

Watch Items

Trading very close to its 52-week low — worth checking whether this reflects a temporary setback or a structural problem.
Cross-check against the company's latest quarterly filing / investor presentation before acting.

DalalBaazaar Thesis

StrongFinancial Health · Growth

MiddlingBusiness Quality · Profitability

WeakValuation · Risk

Points for each in the Score ↑

Good business, demanding price

The quality is real and the price already reflects it. Buying here is a bet that the business keeps compounding for long enough to grow into the multiple — which good businesses often do, but it removes the margin for error that a lower price would have given you.

1 of 5 tripwires tripped — Free cash flow remains positive · see Key things to watch ↑